BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36470752)

  • 1. Risk of Hematologic Malignancies in Elderly Patients With Ankylosing Spondylitis: A Cohort Study and Systematic Review.
    Alehashemi S; Ward MM
    Mayo Clin Proc; 2023 Jan; 98(1):100-110. PubMed ID: 36470752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk for malignant lymphoma in ankylosing spondylitis: a nationwide Swedish case-control study.
    Askling J; Klareskog L; Blomqvist P; Fored M; Feltelius N
    Ann Rheum Dis; 2006 Sep; 65(9):1184-7. PubMed ID: 16414970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-cell maturation antigen expression across hematologic cancers: a systematic literature review.
    Dogan A; Siegel D; Tran N; Fu A; Fowler J; Belani R; Landgren O
    Blood Cancer J; 2020 Jun; 10(6):73. PubMed ID: 32606424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and mortality of patients with hematologic malignancies and COVID-19: a systematic review.
    Kim JS; Lee KH; Kim GE; Kim S; Yang JW; Li H; Hong SH; Ghayda RA; Kronbichler A; Koyanagi A; Jacob L; Shin JI; Smith L
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11926-11933. PubMed ID: 33275265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Second cancers in hematologic malignancies (epidemiologic observations from a 20-year period)].
    Jakó J; Szerafin L; Nagy P
    Orv Hetil; 2005 Mar; 146(10):461-9. PubMed ID: 15835344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pemphigus and hematologic malignancies: A population-based study of 11,859 patients.
    Kridin K; Zelber-Sagi S; Comaneshter D; Batat E; Cohen AD
    J Am Acad Dermatol; 2018 Jun; 78(6):1084-1089.e1. PubMed ID: 29198780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in mortality associated with different hematologic malignancies during the pandemic in the United States.
    Fedeli U; Barbiellini Amidei C; Han X; Jemal A
    Int J Cancer; 2024 May; 154(10):1703-1708. PubMed ID: 38335457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost of Disease Progression in Patients with Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, and Non-Hodgkin's Lymphoma.
    Reyes C; Engel-Nitz NM; DaCosta Byfield S; Ravelo A; Ogale S; Bancroft T; Anderson A; Chen M; Matasar M
    Oncologist; 2019 Sep; 24(9):1219-1228. PubMed ID: 30808814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematologic malignancies in patients with cryoglobulinemia: association with autoimmune and chronic viral diseases.
    Trejo O; Ramos-Casals M; López-Guillermo A; García-Carrasco M; Yagüe J; Cervera R; Font J; Ingelmo M
    Semin Arthritis Rheum; 2003 Aug; 33(1):19-28. PubMed ID: 12920693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating the risk of developing secondary hematologic malignancies in patients with T1/T2 prostate cancer undergoing diverse treatment modalities: A large population-based study.
    Mo X; Zhou M; Yan H; Chen X; Wang Y
    Cancer Med; 2021 Aug; 10(15):5338-5346. PubMed ID: 34189859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wage-subsidised employment as a result of permanently reduced work capacity in a nationwide cohort of patients diagnosed with haematological malignancies.
    Horsboel TA; Nielsen CV; Nielsen B; Andersen NT; De Thurah A
    Acta Oncol; 2015 May; 54(5):743-9. PubMed ID: 25752974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parents' ages at birth and risk of adult-onset hematologic malignancies among female teachers in California.
    Lu Y; Ma H; Sullivan-Halley J; Henderson KD; Chang ET; Clarke CA; Neuhausen SL; West DW; Bernstein L; Wang SS
    Am J Epidemiol; 2010 Jun; 171(12):1262-9. PubMed ID: 20507900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignancies in Patients with Inflammatory Bowel Disease: A Single-Centre Experience.
    Madanchi M; Zeitz J; Barthel C; Samaras P; Scharl S; Sulz MC; Biedermann L; Frei P; Vavricka SR; Rogler G; Scharl M
    Digestion; 2016; 94(1):1-8. PubMed ID: 27318857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global burden of hematologic malignancies and evolution patterns over the past 30 years.
    Zhang N; Wu J; Wang Q; Liang Y; Li X; Chen G; Ma L; Liu X; Zhou F
    Blood Cancer J; 2023 May; 13(1):82. PubMed ID: 37193689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant (Diffuse) Mesothelioma in Patients With Hematologic Malignancies: A Clinicopathologic Study of 45 Cases.
    Li X; Brownlee NA; Sporn TA; Mahar A; Roggli VL
    Arch Pathol Lab Med; 2015 Sep; 139(9):1129-36. PubMed ID: 25844559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased risk for lymphoid and myeloid neoplasms in elderly solid-organ transplant recipients.
    Quinlan SC; Morton LM; Pfeiffer RM; Anderson LA; Landgren O; Warren JL; Engels EA
    Cancer Epidemiol Biomarkers Prev; 2010 May; 19(5):1229-37. PubMed ID: 20406959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When hematologic malignancies meet COVID-19 in the United States: Infections, death and disparities.
    Wang Q; Berger NA; Xu R
    Blood Rev; 2021 May; 47():100775. PubMed ID: 33187811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary Sjögren's syndrome is associated with increased risk of malignancies besides lymphoma: A systematic review and meta-analysis.
    Zhong H; Liu S; Wang Y; Xu D; Li M; Zhao Y; Zeng X
    Autoimmun Rev; 2022 May; 21(5):103084. PubMed ID: 35341972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic lupus erythematosus is associated with increased incidence of hematologic malignancies: a meta-analysis of prospective cohort studies.
    Apor E; O'Brien J; Stephen M; Castillo JJ
    Leuk Res; 2014 Sep; 38(9):1067-71. PubMed ID: 25052307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risks of solid cancers in elderly persons with osteoarthritis or ankylosing spondylitis.
    Ward MM; Alehashemi S
    Rheumatology (Oxford); 2020 Dec; 59(12):3817-3825. PubMed ID: 32442295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.